Effect of short-term hyperglycemia on protein kinase C alpha activation in human erythrocytes

Review of Diabetic Studies

Volumn 9, Issue 2-3, 2012, Pages 1-23

  Livshits, Leonid ^a   Srulevich, Ariel ^a   Raz, Itamar ^a   Cahn, Avivit ^b   Barshtein, Gregory ^c   Yedgar, Shaul ^c   Eldor, Roy ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Endocrinology and Metabolism Service   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acute hyperglycemia; Erythrocyte; Protein kinase C

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLUCOSE; GLUCOSE TRANSPORTER 1; HEMOGLOBIN; PHORBOL ESTER; PROTEIN KINASE C ALPHA;

ADULT; ARTICLE; CELL ELONGATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE METABOLISM; ERYTHROCYTE STRUCTURE; ERYTHROCYTE VOLUME; FEMALE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; METABOLIC ACTIVATION; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 84872455346     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000. 321(7258):405-412.
2. Wong WT, Wong SL, Tian XY, Huang Y. Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol 2010. 55:300-307.
3. Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol 2008. 2(6):1130-1138.
4. Constantin A, Constantinescu E, Dumitrescu M, Calin A, Popov D. Effects of ageing on carbonyl stress and antioxidant defense in RBCs of obese type 2 diabetic patients. J Cell Mol Med 2005. 9:683-691.
5. Miller JA, Gravallese E, Bunn HF. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest 1980. 65:896-901.
6. Maeda N, Kon K, Imaizumi K, Sekiya M, Shiga T. Alteration of rheological properties of human erythrocytes by crosslinking of membrane proteins. Biochim Biophys Acta 1983. 735:104-112.
7. Garnier M, Attali JR, Valensi P, Delatour-Hanss E, Gaudey F, Koutsouris D. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 1990. 39:794-798.
8. Bryszewska M, Szosland K. Association between the glycation of erythrocyte membrane proteins and membrane fluidity. Clin Biochem 1988. 21:49-51.
9. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008. 112(10):4284-4291.
10. Fujita J, Tsuda K, Takeda T, Yu L, Fujimoto S, Kajikawa M, Nishimura M, Mizuno N, Hamamoto Y, Mukai E, Adachi T, Seino Y. Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM. Br J Clin Pharmacol 1999. 47(5):499-506.
11. Bareford D, Jennings PE, Stone PC, Baar S, Barnett AH, Stuart J. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus. J Clin Pathol 1986. 39:722-727.
12. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994. 43:1122-1129.
13. Miller JA, Gravallese E, Bunn HF. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest 1980. 65:896-901.
14. Symeonidis A, Athanassiou G, Psiroyannis A, Kyriazopoulou V, Kapatais- Zoumbos K, Missirlis Y, Zoumbos N. Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients. Clin Lab Haematol 2001. 23(2):103-109.
15. Umudum F, Yucel O, Sahin Y, Bakan E. Erythrocyte membrane glycation and NA(+)-K(+) levels in NIDDM. J Diabetes Complications 2002. 16:359-362.
16. Le Devehat C, Khodabandehlou T, Vimeux M. Relationship between hemorheological and microcirculatory abnormalities in diabetes mellitus. Diabetes Metab 1994. 20:401-404.
17. Baines AJ. The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life. Protoplasma 2010. 244:99-131.
18. de Oliveira S, Silva-Herdade AS, Saldanha C. Modulation of erythrocyte deformability by PKC activity. Clin Hemorheol Microcirc 2008. 39:363-373.
19. George A, Pushkaran S, Li L, An X, Zheng Y, Mohandas N, Joiner CH, Kalfa TA. Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species. Blood Cells Mol Dis 2010. 45(1):41-45.
20. Manno S, Takakuwa Y, Mohandas N. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J Biol Chem 2005 280:7581-7587.
21. Palfrey HC, Waseem A. Protein kinase C in the human erythrocyte. Translocation to the plasma membrane and phosphorylation of bands 4.1 and 4.9 and other membrane proteins. J Biol Chem 1985. 260:16021-16029.
22. Ling E, Danilov YN, Cohen CM. Modulation of red cell band 4.1 function by cAMP-dependent kinase and protein kinase C phosphorylation. J Biol Chem 1988. 263:2209-2216.
23. Ceolotto G, Sartori M, Felice M, Clari G, Bordin L, Semplicini A. Effect of protein kinase C and insulin on Na+/H+ exchange in red blood cells of essential hypertensives. J Hum Hypertens 1999. 13:321-327.
24. Deziel MR, Lippes HA, Rampal AL, Jung CY. Phosphorylation of the human erythrocyte glucose transporter by protein kinase C: localization of the site of in vivo and in vitro phosphorylation. Int J Biochem 1989. 21:807-814.
25. Enyedi A, Elwess NL, Filoteo AG, Verma AK, Paszty K, Penniston JT. Protein kinase C phosphorylates the a forms of plasma membrane Ca2+ pump isoforms 2 and 3 and prevents binding of calmodulin. J Biol Chem 1997. 272:27525-27528.
26. Zancan P, Sola-Penna M. Regulation of human erythrocyte metabolism by insulin: cellular distribution of 6-phosphofructo-1-kinase and its implication for red blood cell function. Mol Genet Metab 2005. 86:401-411.
27. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010. 106:1319-1331.
28. Livshits L, Caduff A, Talary MS, Lutz HU, Hayashi Y, Puzenko A, Shendrik A, Feldman Y. The role of GLUT1 in the sugar-induced dielectric response of human erythrocytes. J Phys Chem B 2009. 113(7):2212-2220.
29. Newton AC. Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 2010. 298:E395-E402.
30. Bornancin F, Parker PJ. Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Calpha. Curr Biol 1996. 6:1114-1123.
31. Goel G, Makkar HP, Francis G, Becker K. Phorbol esters: structure, biological activity, and toxicity in animals. Int J Toxicol 2007. 26:279-288.
32. Komarova SV, Mosharov EV, Vitvitsky VM, Ataullakhanov FI. Adenine nucleotide synthesis in human erythrocytes depends on the mode of supplementation of cell suspension with adenosine. Blood Cells Mol Dis 1999. 25:170-179.
33. Relevy H, Koshkaryev A, Manny N, Yedgar S, Barshtein G. Blood bankinginduced alteration of red blood cell flow properties. Transfusion 2008. 48:136-146.
34. Carruthers A. Facilitated diffusion of glucose. Physiol Rev 1990. 70:1135-1176.
35. Cohen CM, Foley SF. Phorbol ester- and Ca2+-dependent phosphorylation of human red cell membrane skeletal proteins. J Biol Chem 1986. 261:7701-7709.
36. Chien S. Red cell deformability and its relevance to blood flow. Annu Rev Physiol 1987. 49:177-192.
37. Helgerson AL, Carruthers A. Equilibrium ligand binding to the human erythrocyte sugar transporter. Evidence for two sugar-binding sites per carrier. J Biol Chem 1987. 262:5464-5475.
38. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995. 270:28495-28498.
39. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992. 258:607-614.
40. Witters LA, Vater CA, Lienhard GE. Phosphorylation of the glucose transporter in vitro and in vivo by protein kinase C. Nature 1985. 315:777-778.
41. Bevers EM, Comfurius P, Dekkers DW, Harmsma M, Zwaal RF. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance. Biol Chem 1998. 379:973-986.
42. Bevers EM, Comfurius P, Dekkers DW, Zwaal RF. Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta 1999. 1439:317-330.
43. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M, Eisele K, Podolski M, Huber SM, Wieder T, Lang F. Protein kinase C mediates erythrocyte programmed cell death following glucose depletion. Am J Physiol Cell Physiol 2006. 290(1):C244-C253.
44. Riquelme B, Foresto P, D'Arrigo M, Valverde J, Rasia R. A dynamic and stationary rheological study of erythrocytes incubated in a glucose medium. J Biochem Biophys Methods 2005. 62(2):131-141.
45. Shin S, Ku YH, Suh JS, Singh M. Rheological characteristics of erythrocytes incubated in glucose media. Clin Hemorheol Microcirc 2008. 38:153-161.
46. Resmi H, Akhunlar H, Temiz Artmann A, Guner G. In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct 2005. 23:163-168.
47. DECODE Study Group, EDEG. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003. 26(3):688-696.
48. Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004. 47:385-394.
49. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002. 87:978-982.
50. Govekar RB, Zingde SM. Protein kinase C isoforms in human erythrocytes. Ann Hematol 2001. 80:531-534.
51. Brick-Ghannam C, Ericson ML, Schelle I, Charron D. Differential regulation of mRNAs encoding protein kinase C isoenzymes in activated human B cells. Hum Immunol 1994. 41:216-224.
52. Gruber T, Hermann-Kleiter N, Pfeifhofer-Obermair C, Lutz-Nicoladoni C, Thuille N, Letschka T, Barsig J, Baudler M, Li J, Metzler B, et al. PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo. Mol Immunol 2009. 46:2071-2079.
53. Pontremoli S, Melloni E, Sparatore B, Michetti M, Salamino F, Horecker BL. Isozymes of protein kinase C in human neutrophils and their modification by two endogenous proteinases. J Biol Chem 1990. 265:706-712.